Institut Integrated BioBank of Luxembourg
Date of Award
Type 1 Diabetes, Prevent & Delay
Term of Grant
GPPAD Biobank - SINT1A
Funds will support a biobank of samples from the Supplementation with b. INfantis for mitigation of Type 1 diabetes Autoimmunity (SINT1A) trial, in partnership with investigators from the Global Platform for the Prevention of Autoimmune Diabetes.